Skip to main content
Clinical Trials/IRCT20180416039326N3
IRCT20180416039326N3
Completed
Phase 2

Comparison of the sedative effect with Dexmedetomidine-Midazolam and Fentanyl- Midazolam in patients who candidated for Phacoemulsification cataract surgery referred to Isfahan Feyz hospital from 2017-2018

Esfahan University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cataract surgery.
Sponsor
Esfahan University of Medical Sciences
Enrollment
70
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients aged 18–85 years old ASA class 1 \& 2 scheduled for phacoemulsification cataract surgery

Exclusion Criteria

  • refusing, mentally challenged patients , history of chronic use of sedatives, narcotics or alcohol , allergy to any of the study medications , patients with severe chronic obstructive pulmonary disease, Asthma,, history of cardiac disease (cardiac block and bradycardia) bradycardia (heart rate less than 50 beats per minute), systolic blood pressure less than 90 mm, Severe hepatic failure, uncontrolled diabetes, left ventricular failure (EF less than 30\), and cerebrovascular disease,severe renal failures

Outcomes

Primary Outcomes

Not specified

Similar Trials